FMI Reveals Impressive Growth: Needle-Free Injectors Market Projected to Surpass US$ 42.79 Billion at 12% CAGR between 2022 and 2032

In a recent study conducted by FMI, it is projected that the global needle-free injectors market will experience substantial growth at an impressive 12% Compound Annual Growth Rate (CAGR) between 2022 and 2032. By the conclusion of this evaluation period, the market is anticipated to reach a valuation of approximately US$ 42.79 Billion.

This remarkable growth is primarily attributed to the increasing demand for faster drug delivery, serving as a pivotal driver for the needle-free injector market. Furthermore, the burgeoning healthcare sector and the rising popularity of cosmetic surgeries are contributing significantly to the heightened demand for needle-free injectors.

Notably, between 2017 and 2021, the industry demonstrated substantial growth, achieving a noteworthy value CAGR of 8%, culminating in a market value of US$ 12.3 Billion. The utilization of advanced spring-loaded jet injectors has been a key factor propelling market growth. Moreover, the approvals granted by government authorities to expand the utilization of needle-free injectors are further expediting the market’s demand.

Click Here to Access More Insights on this Market, Get A Sample Report
https://www.futuremarketinsights.com/reports/sample/rep-gb-13960

Geographically, US is the largest contributor to the needle-free injectors market. This is owing to the growing prevalence of chronic diseases in the region. The strong presence of healthcare sectors in Germany, Japan and China too are accelerating the use of needle-free injectors. In the upcoming years, increasing inclination towards minimally invasive surgeries will increase the sales of needle-free injectors.

Key Takeaways from the Market Study

• By load type, the projectile injections segment is expected to expand at a CAGR of 13.9% during the forecast period.
• By technology, spring-loaded jet injector segment will dominate the market, holding 47.1% of the revenue share in 2022.
• By application, drug delivery is expected to hold the leading share in the market, accounting for 65.0% of the revenue share in 2022.
• With 79.5% of the revenue share, reusable needle-free injectors are expected to dominate the market in 2022
• By end-user, hospitals are expected to be the primary end-user, accounting for over 33.4% market share during the forecast period.
• US is expected to be a leading market across North America, accounting for over 94.0% of the market in 2022
• Germany is expected to dominate the Europe, holding 29.4% Europe’s market share through 2032
• Japan is projected to hold over 34% share in the East Asia market, exhibiting growth at a CAGR of 11.7% during the forecast period
• China led the East Asia market with more than 46.8% share and is projected to expand at a CAGR of 12.0% through 2032.

Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-13960

“The healthcare sector along with the cosmetic industry are the largest contributors to needle-free injectors market. Increasing demand for minimally-invasive surgeries is further accelerating the demand for needle-free injectors” states an FMI analyst

Market Competition

Key players in the needle-free injectors market are Gerresheimer AG, Pfizer Inc., Antares Pharma, CSL Limited (Seqirus UK Limited), Crossject, Portal Instruments, Ferring Pharmaceuticals, PharmaJet Inc., PenJet Corporation

• In August 2022, University of Adelaide began the human trail of omicron COVID vaccine booster using Pharma-Jet needle-free systems. In addition, the vaccines has been administered using PharmaJet Tropis NFIS.
• Portal Instruments, a key player in the needle-free injectors market is focusing on developing needle-free injectors for different chronic ailments and creating awareness regarding painless injections.

Key Segments Profiled In The Needle-Free Injectors Market Industry Survey

Needle-Free Injectors Market by Load:

• Needle-Free Injectors by Liquid Injections
• Needle-Free Injectors by Powder Injections
• Needle-Free Injectors by Projectile Injections

Needle-Free Injectors Market by Technology:

• Needle-Free Injectors by Spring-loaded jet injector
• Needle-Free Injectors by Battery-powered jet injector
• Needle-Free Injectors by Gas-powered jet injector

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/13960

Needle-Free Injectors Market by Delivery Site:

• Needle-Free Injectors by Intra dermal injectors
• Needle-Free Injectors by Intramuscular injectors
• Needle-Free Injectors by Subcutaneous injectors

Needle-Free Injectors Market by Application:

• Needle-Free Injectors by Drug Delivery
• Needle-Free Injectors by Vaccines
• Needle-Free Injectors by Cosmetic
• Needle-Free Injectors by Others

Needle-Free Injectors Market by End User:

• Needle-Free Injectors by Home Care Settings
• Needle-Free Injectors by Long Term Care Centers

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube